CATEGORY: FOODS & NUTRIENTS
The fish oil arrived exactly where it was supposed to go. It just didn’t do anything once it got there. Across a two-year trial of 365 older adults at raised risk of dementia, high-dose DHA capsules sharply lifted omega-3 levels in the fluid that bathes the brain, yet memory and thinking scores rose by the same couple of points in the supplement and placebo groups, a difference of less than a tenth of a point, and the brain’s memory hub shrank no more slowly on scans.1
Capsules, Spinal Taps and a Question of Delivery
A doubt has always shadowed fish oil’s failures in dementia prevention: maybe the dose was too low, or the oil never reached the brain at all. Researchers at the University of Southern California built the PreventE4 trial to close that loophole. They recruited adults aged 55 to 80 who rarely ate fish, each with at least one dementia risk factor, and nearly half carried the APOE4 gene variant that raises Alzheimer’s risk. A computer’s draw gave each person either five daily capsules adding up to 2,000 mg of DHA, the omega-3 fat most concentrated in brain tissue, or identical placebo oil for two years. A subgroup agreed to spinal taps so the team could verify whether swallowed DHA truly raised levels in the nervous system.
Proof of Delivery, No Sign of Protection
Delivery worked. Six months in, the spinal-fluid omega-3 ratio had climbed strongly on the supplement and drifted slightly down on placebo, meeting the trial’s primary goal. Protection didn’t follow. After two years, scores on a standard memory-and-thinking battery had improved about 2.7 points in each group. MRI scans found no slower shrinkage of the hippocampus, the seahorse-shaped memory center that Alzheimer’s attacks early. Carrying APOE4 changed nothing about the result, which ran against the researchers’ own starting idea that carriers might respond differently. Side effects matched placebo. The team concluded that DHA on its own isn’t enough to protect aging cognition, a verdict they note fits the string of earlier trials that came up empty.1
Where That Leaves the Fish-Oil Bottle
A few limits soften the verdict. These volunteers stayed cognitively healthy and declined very little over the two years, which leaves a supplement little decline to prevent, and pandemic-era dropouts thinned the final numbers. The capsules also aren’t a stand-in for fish itself, since meals carry other nutrients and habits along with the DHA. Still, for anyone swallowing fish oil specifically to protect memory, this is an unusually direct test of that hope. It came back negative.
Key Takeaways
- Two years of high-dose DHA raised omega-3 levels in the fluid around the brain, confirming the supplement reached its target.
- Memory and thinking scores still improved essentially identically on DHA and placebo, and brain scans showed no slower shrinkage.
- Participants were healthy and barely declined during the trial, so a benefit in people already losing ground isn’t ruled out.
References
- Yassine HN, Ghasem Pour S, Juarez M, et al. CNS target engagement of high-dose DHA supplementation in older adults at risk for dementia: a randomised, double-blind, placebo-controlled trial. eBioMedicine. 2026;129:106316. link